ABSTRACT
INTRODUCTION
For gene transfer into quiescent or postmititotic cells, particularly those in the brain, herpes simplex virus type 1 (HSV-l) exhibits a number of desirable characteristics that include a wide hostcell range, the capability to infect nondividing cells, a long-term persistence and the capacity to accommodate large molecules of foreign DNA (for review see Reference 35) . There are two types of replication-incompetent HSV-l vectors: those based on recombinant viral genomes (8, 11) and defective HSV-l vectors (14, 33) , which are composed of a plasmid, or amplicon, which is packaged into virus particles in the presence of a helper virus. Defective HSV-l vectors contain the HSV-l sequences necessary for replication (an origin of DNA replication) and packaging (an a sequence) and can be manipulated easily by standard recombinant DNA techniques . Consequently, there has been a growing interest in their potential uses in gene transfer experiments.
Defective HSV-l vectors have been used to perturb neuronal physiology both in culture (1, 2, 15, 19, 36) , and in the rat brain (9, 19) . These initial physiological experiments, while encouraging, have also illuminated the limitations of the current packaging system. In theory, by using a sufficient amount of vector, it should be possible to genetically modify virtually all of the target cells. However, with the present HSV-l vector systems, cytotoxic effects associated with the systems place an upper limit on the concentrations of vector that can be used. In spite of the inability of replication-incompetent helper viruses to progress through the lytic cycle in normal cells, cytopathic effects can result both from proteins present in HSV-l particles and from expression of HSV-l immediate-early (IE) genes (20) . In addition, during the packaging of defective HSV-l vectors using specific helper viruses, wild-type (wt) HSY-1 revertants arise at a finite frequency (16, 20) and contribute to the cytotoxicity. Consequently, to reduce the cytopathic effects of defective HSY-1 vectors, two of the goals of this study were to increase the proportion of the vector with respect to both the helper virus and wt HSY-1.
Specific replication-incompetent HSY-1 mutants are available as candidates for the helper virus to package defective HSY-I vectors . Of the five IE genes, only IE 2 (lCP27 or Ymw63) and IE 3 (ICP4 or Ymw175) are required for the lytic cycle of HSY-1 (reviewed in Reference 35) . Past work in our laboratory as well as others' has concentrated on the use of IE 3 mutants as helper viruses since IE 3 mutants have a restrictive phenotype in that under nonpermissive conditions they express few HSY-1 genes (6, 27) . However, the titers of IE 3 deletion mutants obtained in cultured fibroblasts are reduced compared with wt HSY-1. Therefore, we examined the effectiveness of an IE 2 deletion mutant as the helper virus in the packaging procedure.
The prototype-defective HSY-1 vector, pHSYlac, uses the IE 4/5 promoter to regulate expression of the Escherichia coli lacZ gene, and many other vectors also use the HSY-I IE 4/5 promoter to direct recombinant gene expression. Within the context of the HSY-1 genome, this promoter appears to be inactive during latency (reviewed in Reference 35) . In contrast, in transgenic mice, the IE 3 promoter is active in at least some cell types in the adult brain (24) , defective HSY-1 vectors harboring three different IE promoters support long -term expression in cultured peripheral neurons (32) and, in the adult rat brain, injection of defective vectors containing the IE 4/5 promoter results in expression in at least some striatal cells for up to one year (9) . Therefore, we undertook a quantitative study of the stability of expression from pHSYlac in cultured cortical neurons. Also, since many more viral proteins are expressed by IE 2 mutants compared with IE 3 mutants, we investigated the effects of an IE 2 deletion mutant helper virus on recombinant gene expression.
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MATERIALS AND METHODS

Cell Culture and Virus Growth
Cell lines were cultured in Dulbecco's modified essential medium (DMEM) supplemented with penicillin/streptomycin (both from Life Technologies, Gaithersburg, MD, USA) and 4 mM glutamine at 37°C in humidified incubators containing 5% CO 2 , PC-12 cells (18) were grown in 10% horse serum (HS) and 5% fetal bovine serum (FBS) (both from Life Technologies), and NIH3T3 mouse fibroblasts were grown in DMEM containing 10% calf serum. DMEM containing 10% FBS was used for all other cell lines including 2-2 cells (31); YERO cells which contain the IE 2 gene; E5 cells (7); YERO cells which contain the IE 3 gene; RR1 cells (20) and M64A cells (5); BHK cells which contain the IE 3 gene; MN9D cells (4), a cell line derived from the human mesencephalon, which has some characteristics of a catecholaminergic central nervous system neuron; and CY-1 and BHK-21 monkey fibroblasts.
Dissociated rat cortical cell cultures containing a mixture of neurons and glia were prepared from postnatal rats (days 1-2) by standard methods (22) with the following modifications: cells were plated into poly-u-lysine-treated 24-well plates (3.8 x 105 cells per well) in DMEM supplemented with 10% heat-inactivated FBS, 4 mM glutamine, 21 mM glucose and 38 mM NaHC0 3 . The cultures were maintained at 37°C in a humidified incubator containing 5% CO 2 , After 1 week, cell replication was inhibited by exposure to 10-5 M cytosine arabinoside (Sigma Chemical, St. Louis, MO, USA) for 1 day, after which the medium was replaced with DMEM containing 1% heat-inactivated HS. Cultures were used for experiments after 14 days.
The wt HSY-1 strain 17+ (3) was grown on BHK-21 cells . The HSY-1 strain 17+ IE 3 deletion mutant D30EBA (27) was grown initially on M64A cells, but since this gave rise to revertants at a significant frequency (between 10-5 and 10-4), the virus was later grown on RR1 cells. The IE 3 deletion mutant d120 (6), derived from the KOS strain (30), was grown on E5 cells; and the IE 2 deletion mutant 5dl1. 2 (23) , also derived from KOS strain, was grown on 2-2 cells.
The wt HSY-1 strain 17+ was assayed on BHK-21 and CY-1 cells, the IE 2 deletion mutant virus 5dl1.2 was assayed on 2-2 cells and the IE 3 deletion mutant viruses d120 and D30EBA were assayed on E5 cells . Plaque assays were performed by standard methods (34) .
Titers of vectors were measured on PC-12 cells (14) with the following modifications: 24-well plates were coated with poly -p-lysine (500 ul, of 20 ug/ml, aqueous solution, 10 min), and after removal of the coating solution, PC-12 cells were plated at 5 x 105 cells per well. The next day the cells were infected, and 1 day later the cells were fixed in 4% paraformaldehyde, 100 mM NaP0 4, pH 7.0, for 20-60 min . The cells were washed once with PBS (1.5 mM KH 2P04, 13.5 mM Na2HP04, 2.7 mM KCI and 137 mM NaCI) and once with GST (2% goat serum and 0.2% Triton® X-100 in PBS). Detection of~-galactosidase in situ was performed essentially as previously described (29) by incubating the cells at 37°C for 24 h in PBS containing 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mM MgCI 2, 0.02% Nonidet'v P-40, 0.01 % sodium deoxycholate and 1 mg/mL 5-bromo-4-chloro-3-indoly 1-~-n-galactoside (X-gal; Sigma Chemical). Titers of vector were expressed as infectious particles/mL.
Lactate Dehydrogenase Efflux Assays
As an indication of cell death in cortical cultures, extracellular lactate dehydrogenase (LDH) enzyme activity was measured as described by Koh and Choi (22) . Briefly, 24 h after infection, 75% of the medium in each well of a 24-well plate (400 ul.) was replaced with HBCSS, pH 7.4 (86 .5 mM NaCI, 5.4 mM KCI, 0.8 mM MgCl b 1.8 mM CaCI 2, 20 mM glucose, 20 mM HEPES, 26 mM NaHC0 3 and 10 mM NaOH) . After 3 consecutive medium exchanges, the cells were returned to the incubator, and LDH assays were performed at both 4 and 7 days after infection as follows : 50-ilL aliquots of
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RESULTS
Use of an IE 2 Deletion Mutant as the Helper Virus
The structures of the 3 deletion mutant viruses used in this study and the cell lines used for their growth are shown in Figure 1 . Two of the mutants, D30EBA (27) and d120 (6) , contain a deletion in the IE 3 gene , while the third mutant, 5dll .2 (23), harbors a deletion in the IE 2 gene . Previous work in our laboratory (16) -.
a discontin uous sucrose gradient consisting of 7 mL of 60% sucrose, 6 mL of 30% sucrose and 3 mL of 10% sucrose in a 40-mL Beckman Instruments (Fullerto n, CA, USA) SW28 ultracentrifuge tube. Sucrose solutions were made using sterile PBS and stored at 4°C. After centrifugation for 1 h at l 25000x g, the virus at the interface between the 30% and 60% sucrose solutions was collected in a volume of approximately 2 mL. After dilution with approximately 18 mL PBS, the virus was centrifuged at l25000x g for 1 h. The pellet was resuspended in 200 ul, PBS/l 0% sucrose and stored in aliquots at -70°C. the culture medium were added to a NADH/pyruvate mixture, and the change in absorbance at 340 nm was monit ored. Enzyme units were calibrated using purified LDH (Sigma Chemical) .
Packaging of Defective HSV-I Vectors
Two days before transfection, cells were trypsinized and seeded at 3 x 10 5 cells per 60-mm dish in 5 mL DMEM containing 10% FBS . For each transfection sample, 2 ug plasmid DNA were diluted to 100 ul, with OPTI-MEM® and mixed with 100 ut. OPTI-MEM containing 12 ut. Lipofectamine" (both from Life Technologies) . After allowing liposome format ion for 20 min at room temperature, OPTI-MEM was added to a final volume of 3 mL, and the mixture was overlaid onto the cells that had been washed once with OPTI-MEM . The cells were incubated for 5 h at 37°C and washed 3 times with PBS, once with DMEM conta ining 10% FBS, and then 5 mL DMEM containing 10% FBS were added. On the next day, at least 20 h after the PBS washes, the medium was removed and replaced with 5 mL DMEM containing 5% FBS containing approximately 6 x 10 5 plaque -forming units (pfu) of helper virus. One day later, the cells were checked for cytopathic effects and harvested by scraping the cells into the culture medium . The virus (4 mL) from this initial transfection/infection, designated pO, was passaged on fresh cells 3 times to increase both the ratio of vector to helper and the total amount of virus . For each passage, the cells were seeded 2 days prior to infection at the following densities : p l , 1 plate per sample at 4 x 10 5 cells per 60-mm plate; p2, 2 plates per sample at 1 x 10 6 cells per 100-mm plate; and p3, 4 plates per sample at' 1 x 10 6 cells per 100-mm plate. The volumes of virus used to infect the respective passages were 4 mL pO diluted with 4 mL DMEM containing 5% FBS; 8 mL p l diluted with 12 mL medium; and 16 mL p2 diluted with 24 mL medium.
Virus Pu rification
Virus was purified as described (34) with the following modifications : virus (20 mL of p3) was centrifuged through
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was to reduce the levels of wt HSV-l. Since growth of D30EBA on M64A cells gives rise to wt revertants at a relatively high rate (l0-5 to 10-4 ) , we replaced M64A cells with RRI cells (20) . Within the sensitivity of our pfu assay (10-6 ) , we rarely detected any wt HSV-1 revertants in any of the virus stocks grown for up to 3 serial passages on RRI cells . Similar results were obtained in packaging experiments that used d120 as the helper virus, which was grown on E5 cells (7), or 5dll.2 as the helper virus, which was grown on 2-2 cells (31). In one experiment using 5dl1.2 as the helper virus, no wt HSV-1 was observed even after 10 serial passages . However, in approximately 5% of the virus stocks , we observed wt HSV-1 at a frequency of approximately 10-6 . These much lower levels of wt HSV-1 have allowed increased amounts of vectors to be used in physio logical experiments with cultured neurons compared with vectors packaged with D30EBA. Furthermore, no rats died from HSV encephalitis (data not shown) following injection of vectors packaged using d120 or 5dl1.2, although injection into the adult rat brain of vectors packaged using D30EBA resulted in death of a significant fraction of the rats within 2 weeks following gene transfer.
Our next goal was to improve the packaging procedure to consistently obtain both a high titer of vector (:2:10 6/mL) and a favorable ratio ofvector to helper (:2:1). Two modifications were made: first, we found that transfection of the vector DNA was found to be more efficient and reproducible using the Lipofectamine method in place of the calcium phosphate method, and second, we noted that use of the IE 2 deletion mutant 5dl1.2 as the helper virus yielded vector titers that were consistently higher. than we had previously observed with either of the IE 3 deletion mutants D30EBA or d120. The titers from a representative experiment in which pHSV1ac was packaged using either 5dl1.2 or d120 as the helper virus is shown in Figure 2 . The number of infectious particles of pHSV1ac present at each passage dur-. ing the packaging was higher using 5dl1.2 compared with dl20 ( Figure  2a) . Better growth of pHSV1ac with 464 BioTechniques succeeding passages using 5dl1.2 also resulted in poorer growth of the helper virus (Figure 2b) . Thus, the principal advantage of using 5dl1.2 as the helper virus was a higher ratio of vector to helper (Figure 2c ). Using D30EBA, we can sometimes produce some virus stocks that contain a vector to helper virus ratio of :2: 1:1, but we have as yet been unable to determine the critical parameters. In contrast, using this procedure, packaging vectors using 5dll.2 as the helper virus on 2-2 cells appear to reproducibly yield virus stocks that contain a high ratio of vector to helper virus.
Our prototype vector pHSVlac packaged using 5dll .2 as the helper virus was used to infect several different fibroblast cell lines including CV-l, VERO-E5 , BHK-2l and NIH/3T3 . Since our primary interest in the HSV-1 vector system is to transfer genes into the cells of the nervous system, we also '!'~I~I tested two cell lines showing neuronal characteristics, PC-12 and MN9D cells. One day after infection, efficient expression of I)-galactosidase was observed in all 6 of these cell lines (results not shown); these results are similar to those previously obtained (13,16) using pHSVlac packaged using helper viruses that harbor a mutation in the IE 3 gene (ts K or D30EBA).
Cytotoxicity Caused by IE 2 and IE 3 Deletion Mutant Viruses
Since we are using HSV-l vectors for gene transfer; into neurons, we investigated the cytotoxic effects of the 3 deletion mutant helper viruses in primary rat cortical cultures. The efflux of lactate dehydrogenase (LDH) enzyme activity from injured cells into the culture medium has been used to quantify damage to cortical neuronal cultures (22) . Thus, the effects of infection by D30EBA, d120 or 5dl1.2 on extracellular LDH levels in cultured cortical cells were investigated. Four days after ' " 2 days 9 days 9 days 9 days (+ SdI1.2) (t D30EB A) Figure 7 . Long-term persistence of pHSVlac DNA in cultured cortical cells can be revealed by reactivation of p-galactosidase expression following superinfection with an IE 2 deletion mutant virus. a. Cultures were infected with a low MOl of pHSYlac, superinfected with 5dl1.2 at the time of infection , and 2 days (solid circles) or 9 days (solid square s) after gene transfer, the number of cells expressing~-galactosidase was determined using X-gal staining. Additional cultures were infected with the same low MOl of pHSYlac, superinfected with 5dl1.2 at 7 days after gene transfer, and 9 days after gene transfer (open squares), the number of cells expressing~ galactosidase was determined. b. Cultures were infected with pHSYlac (packaged with 5dl1.2), and after 2 days (lst bar) or 9 days (last 3 bars),
-galactosidase expression was assayed using Xgal staining. Of the 3 sample sets assayed after 9 days, the first was stained with no additional treatments, while the second and third sets were superinfected with I x 10 5 pfu of 5dl1.2 (+ 5dl1.2) or 1 x 10 5 pfu of D30EBA (+ D30EBA), respectively. Both superinfections were done 2 days before X-gal staining (7 days after infection). The mean number of X-gal positive cells in 3 cultures is shown , and the error bars indicate the standard error of the mean. pHSYlac packaged using D30EBA were superinfected with increasing amounts of D30EBA. One and seven days later, the cultures were assayed for expression of~-galactosidase ( Figure  6 ). The enhancement of expression caused by superinfection with 5dll .2 was no longer present after one week. Figure 5 . Influence of superinfection with elther IE 2 or IE 3 deletion mutant viruses on expression of p-galactosidase from pHS Viae in cultured cortical cells. Cultures were infected with pHSYlac packaged using either D30EBA (a) or 5dll . 2 (b) . The cultures were immediately superinfected with increasing amounts of D30EBA (triangles), d120 (squares) or 5dl1.2 (circles), and 1 day later the number of cells expressing~-galactosidase was determined using X-gal staining.
The IE 4/5 promoter fragment present in pHSYlac contains a binding site for the IE 3 gene product, and therefore, its activity may be influenced by IE 3 protein. We tested this hypothesis by using either D30EBA, d120 or 5dll.2 to coinfect neurons with pHSYlac. pHSYlac packaged with either 5dll.2 or D30EBA was used to infect neurons at a low multiplicity of infection (MOl), and then increasing amounts of D30EBA, d120 or 5dl1.2 were added . On the following day, the number of cells expressing~-galactosi dase was determined ( Figure 5 ). Coinfection with 5dll.2 increased the number of cells expressing~-galactosidase irrespective of the helper virus used, whereas both d120 and D30EBA had a minimal effect. Previous studies using CY-I or PC-12 cells infected with pHSYlac packaged using ts K, an HSY-I strain bearing a temperature-sensitive mutation in the IE 3 gene, have indicated that ts K had a minimal effect on stongly influenced by HSY-l gene expression. Another possibility is that the IE 4/5 promoter is affect ed by factors carried within HSY-l particl es, such as the YP 16 transactivator prote in, and that the amounts of these factors or their stabilities differ between the different mutant helper virus particles.
Rescue of~-Galactosidase Expression by Superinfection with
Sdl1.2
We reasoned that if the decr ease in the number of~-galactosidas e positive cells with time after infection with pHSYl ac was due to inactivation of the IE 4/5 promoter, then it might be possible to rescue recombinant gene expression by superinfection with 5dll .2; in contrast, the death of cells harboring pHSYlac would preclude the rescue of gene expression by superinfection with 5dll .2. Cultures were infected at a low MOl with pHSYlac packaged with 5dll.2 . Immediately or 7 days later, the culture s were superinfected with increasing amo unts of 5dl 1.2, and the number of~-galactosidas e positive cells was assayed 2 and 9 days after gene transfer (Figure 7a ). When cells were superinfected at the same time as infect ion with pHSYlac, an increase in the number of positive cells was observed after 2 days, but not after 9 days. However, superinfection with 5dl1.2 at 7 days after gene transfer resulted in an increase in the number of cells expressing~-gal actosidase at 9 days after gene transfer. To investigate if the IE 3 gene product was required for rescue of recombin ant gene expression, cultures were infected with pHSYl ac packaged with either 5dl 1.2 or D30 EBA and superinfected at 7 days after gene transfer with the same helper virus. The number of cells expressing~-galactosidase was determined at 9 days after gene transfer (Figure 7b ). Superinfection with 5d/1.2, but not D30EBA , increased the number of cells expressing~-gal actosi dase to levels similar to those observed at 2 days after gene transfer. D30EBA directed only a small increase in the number of cells expressing~-galactosi dase, which may be due to the effects of the YP 16 protein contained in HSY-l particles, whereas the much larger enhancement by 5dll.2 may be depend ent Vol. 20, NO. 3 ( 1996) on the IE 3 gene. These results demonstrate that despite a decrease in the level of expression of~-g al actosidas e in some cell s, functional pHSYlac DNA persists in most infec ted cells for at least I week and remains responsive to transactivating factors.
DISCUSSION
Defective HSY-l vectors packaged with D30EBA have been used in physiological experiments (1, 2, 9, 10, 15, 19, 36) . However, there are a number of difficulties in working with the D30EBA pack aging system. When vectors are packaged using D30EBA in M64A cell s, revertants to wt HSY-l arise at a frequency of between 10-5 and 10-4. In addition, when using D30EBA as the helper virus grow n on either M64A or RRI cells, the resulting virus stocks do not consistently contain either a high titer of vector (~106/mL) or a good ratio of vector to helper virus (~I ) . The packaging system described in this report , which uses 5dl l .2 virus (23) grown on 2-2 cells (3 1), consistently produces virus stocks with undetectable levels of wt HSY-I « 10-6 ) and both a high titer of vector (~I 06/mL) and a high ratio of vector to helper (~l ) . The reasons for this are not completely clear but may be related to the efficient growth of 5dll .2 on 2-2 cells. The titers of 5dl1.2 obtained in tiss ue culture do not differ significantly from the titers of wt HSY-I (23), whereas the titers of D30EBA and d 120 obtained following growth on the appr opriate cell line are decrea sed by at least I order of magnitude compared with wt HSY-I (6, 27) .
The stability of express ion of~ galactosidase from pHSY lac was examined in cultured cortical cells. At one week after gene transfer, the number of cells expressing high levels of~ galactosidase was approximately 30% of that observed at 2 days after gene transfer, regardless of the helper virus used for packaging. Superinfection with 5dll .2 directed a transient increase in the number of cells expressing high levels of~-galactosidase, and this procedure was used to demonstrate the persistence of pHSYlac DNA in these cells for 1 week. We have begun similar experiments in the adult rat brain, and preliminary results indicate that most of the cells receiving HSY-l vectors do not support high-level, long-term expression, although HSY-I vecto rs persist in these cells for months, and the level of expression can be elevated by superinfection with 5dll .2.
The primary reason for the decline in the level of reco mbinant gene expression in some cultured cort ical cells is a decrease in promoter activity, although the mechanism medi ating this chang e in promoter activity is not clear. In the HSY-I genome, the IE 4/5 promoter is active only during the immediate-e arly and earl y phases of lytic infection and is down-regulated durin g the late phase (reviewed in References 34 and 35). Furthermore, IE promoters appear to be silent durin g the laten t state (reviewed in Reference 33). However, in transgenic mice containing the lacZ gene regu lated by the IE 3 promoter, constit utive expression of~-gal ac tosidase is observed in many cell types, both inside and outside of the nervous system (24, 25) . Constitutive express ion of a recombinant gene product, although at low levels, is also observed in fibrob last cell lines stably transfected with the IE 3 promoter (26) . Infection of cultured sensory neurons with defective HSY-l vectors that use the IE I, IE 3 or IE 4/5 promo ters res ults in lon gterm ( 10 week ) expression with little decline in the number of cells expre ssing~-gal acto sidase compared to earlier tim es (2 weeks) (32) . However. as described in this report , the numb er of cultured cortical cells showing gene expression from the IE 4/5 promoter declin es to abo ut 30 % after one week. One possible explanation for these results is that there are tissue-specific factors required to support long-term gene expressio n from the IE 4/5 prom oter. Thus, in some cell types (e.g., cort ical neurons), the IE 4/5 prom oter is only activated transiently by factors assoc iated with viral infection, while in other cell types (e.g ., sensory neurons), further activation of the IE 4/5 promoter by cellular factors allows continued gene expression . On the other hand, heterologous promoter s may also be subject to inhibitory influence s by HSY-I sequences. Consistent with this explanation, insertion of the mur ine leuk emia virus long terminal repeat (LTR) promoter into the HSY-I genome results in long-term expression in the peripheral nervous system but only transient expression in motor neurons of the hypoglossal nucleus (8) . These results indicate an inhibitory effect of the HSV-l genome on a promoter that often supports constitutive expression in other experimental contexts. Results using a defective HSV vector containing the preproenkephalin promoter in the adult rat brain indicate that it can direct some expression of the lacZ gene for up to 2 months (21), but no quantitative data are yet available on the stability of gene expression. Our preliminary experiments using vectors containing other cellular promoters indicate a gradual reduction in the number of cells supporting high-level recombinant gene expression. These HSV-l vectors contain the HSV-l oris and a sequences, and it is possible that there are still regulatory elements present in these viral sequences which can reduce in gene expression. Alternatively, events associated with the viral mode of entry into the cell may cause cellular responses that could direct a gradual reduction in gene expression, regardless of the promoter in the defective HSV-l vector. In view of our observation that recombinant gene expression may be reactivated even after promoter shutdown, it will be interesting to observe the behavior of an inducible promoter (17) within the context of defective HSV-l vectors.
Using the 5dl1.2 virus 2-2 cell line packaging system described here, we can consistently produce high-titer vector stocks with low proportions of helper virus and undetectable levels of wt HSV-l . Furthermore, pHS VIae packaged with this system can support long-term (l week) expression in some cultured cortical cells, although promoter activity is decreased in other cells. The observation that functional defective HSV-l vector DNA can persist in neurons in a quantitative and long-term manner indicates that this vector system has the potential to support high-level, long-term gene expression. The properties of the 5dl1.2 virus 2-2 cell line packaging system, in particular the high vector titers, should facilitate studies applying HSV-l vectors both to gene therapy and to questions in neuronal physiology.
